Fever After CAR T-Cell Therapy: New Push for Early Detection of Toxicity
A new review in Blood Research outlines how early detection, risk prediction models, and phenotype-directed treatment are reshaping the management ...
A new review in Blood Research outlines how early detection, risk prediction models, and phenotype-directed treatment are reshaping the management ...
An early study of 28 Korean DLBCL patients found that positive Deauville 4–5 findings on post-CAR T-cell PET/CT scans were ...
A new review explains how targeted immunotherapies are stripping predictive power from traditional risk markers in adult B-cell acute lymphoblastic ...
A new commentary in Cardio-Oncology marks 30 years since Daniela Cardinale coined the term cardio-oncology and presents the first English ...
UC San Francisco scientists engineered B-SYNC CAR-T cells that activate only in the brain and cleared diffuse midline glioma in ...
A three-case report links residual CAR transgene at transplantation to persistent CAR-T donor cells causing mixed chimerism with cytopenia, with ...
A prospective single-center observational study found that patient-reported physical and functional burden after CAR T-cell therapy peaked during hospitalization and ...
A Hong Kong phase II trial of six children found that locally manufactured point-of-care CD19 CAR-T cells, produced in 14 ...
A retrospective study of 109 patients finds that CD19-directed CAR T-cell therapy reduces nodal and extranodal lymphoma tumors to a ...
A National Cancer Institute grant will fund planned OU trials testing whether opaganib can enhance CAR T-cell activity against ultra-high-risk ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine